Influence of complex variant chromosomal translocations in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

Influence of complex variant chromosomal translocations in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

Published:2010-01 Issue:4 Volume:49 Page:506-508
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Stagno Fabio,Vigneri Paolo,Fabro Vittorio Del,Stella Stefania,Cupri Alessandra,Massimino Michele,Consoli Carla,Tambè Loredana,Consoli Maria Letizia,Antolino Agostino,Di Raimondo Francesco

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/02841861003660031

Reference9 articles.

1. Variant Ph translocations in chronic myeloid leukemia

2. Mechanisms of genesis of variant translocation in chronic myeloid leukemia are not correlated with ABL1 or BCR deletion status or response to imatinib therapy

3. Fusion tyrosine kinases: a result and cause of genomic instability

4. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

5. Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective analysis of own long-term experience in studying the BCR::ABL kinase domain mutational status in patients with chronic myeloid leukemia;Oncohematology;2024-09-01

2. Three-way Philadelphia Translocation [t(46, XX, t(9;22;16) (q34;q11.2;q24)] in Chronic Myeloid Leukemia: A Report of Two Cases with Review of the Literature;Journal of Cancer Research and Therapeutics;2024-01-22

3. A Unique Three-Way Variant Philadelphia Chromosome t(6;9;22)(p21.3;q34;q11.2) in a Newly Diagnosed Patient with Chronic Myeloid Leukemia Responded to Flumatinib;OncoTargets and Therapy;2022-09

4. Genomic Mechanisms Influencing Outcome in Chronic Myeloid Leukemia;Cancers;2022-01-26

5. Effects of tyrosine kinase inhibitors for controlling Ph+ clone and additional clonal abnormalities in a chronic myeloid leukemia;Journal of Cancer Research and Therapeutics;2022